New guidelines for treating Crohn's disease emphasize early use of higher-efficacy advanced therapies over step-up approaches. The strongest support went to seven advanced therapies that are all ...
Submissions are supported by data from the Phase 3 Viti-Up clinical studies demonstrating upadacitinib achieved the co-primary endpoints of at least a 50% improvement ...
A quiet problem has followed cancer immunotherapy for years. The immune system can be taught to fight, then it fades.
Medications targeting the neonatal fragment crystallizable receptor have gained attention due to multiple recent FDA ...
Heart failure (HF) is a chronic and progressive cardiovascular condition associated with significant morbidity, mortality and ...
When a child falls ill repeatedly, parents often assume the cause is frequent infections. However, when symptoms persist or occur frequently, especially from early childhood and without any ...
The UK just announced the launch of a randomized controlled trial to evaluate the risks and benefits of puberty-blocking drugs for minors experiencing gender distress. The trial announcement came just ...
Gray Areas On February 4, the American Society of Plastic Surgeons issued a position paper, recommending that transgender minors delay surgical procedures until adulthood. One day later, the American ...
Ready to watch the NFL playoff games Sunday? The NFL conference games this weekend kick off at 3 p.m. ET and 6:30 p.m. ET. The LA Rams slide in at +220 and the New England Patriots at +250 to win ...
Spyre stands out for its deep immunology pipeline, strong cash runway into 2H28, and emerging leadership in TL1A-targeted therapies. With a pro-forma cash position of $783M, SYRE is well-capitalized ...
"Thursday Night Football" on Prime Video play-by-play announcer Al Michaels joins "NFL Schedule Release '25" to break down the matchups of the 2025 NFL season. "Thursday Night Football" on Prime Video ...
Overall, the study suggests that fluoxetine may be a promising adjunctive therapy in severe sepsis by reducing vasopressor ...